SCHEMBL6205935

SCHEMBL6205935

CC(C)(C)C#Cc1cc([N+](=O)[O-])ccc1N

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 5/20 0.51
ALDH1A1 P00352 5/20 0.51
CYP3A4 P08684 3/20 0.51
TSHR P16473 4/20 0.50
HTT P42858 1/20 0.47
CASP3 P42574 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
GAA P10253 1/20 0.46
THRB P10828 1/20 0.46
PTPN11 Q06124 1/20 0.44
VCAM1 P19320 1/20 0.42
ALOX15 P16050 1/20 0.42
MAPT P10636 2/20 0.39
MEN1 O00255 1/20 0.39
GFER P55789 1/20 0.39
KMT2A Q03164 1/20 0.39
LMNA P02545 2/20 0.38
S1PR4 O95977 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17644235 0.82 ALDH1A1 (0.43) TDP1ALDH1A1CYP3A4TSHRHTT
SCHEMBL1465548 0.82 ALDH1A1 (0.45) TDP1ALDH1A1CYP3A4TSHRHTT
SCHEMBL1465483 0.81 LOXL2 (0.41) TDP1ALDH1A1CYP3A4TSHRHTT
SCHEMBL1465485 0.80 MAPT (0.50) TDP1ALDH1A1CYP3A4TSHRHTT
SCHEMBL5718688 0.79 ALDH1A1 (0.50) TDP1ALDH1A1CYP3A4TSHRHTT
SCHEMBL31735891 0.79 TDP1 (0.50) TDP1ALDH1A1CYP3A4TSHRHTT
SCHEMBL15557574 0.79 HSD17B10 (0.53) TDP1ALDH1A1TSHRHTTGAA
SCHEMBL28850334 0.78 CYP3A4 (0.49) TDP1ALDH1A1CYP3A4TSHRHTT
SCHEMBL6776859 0.78 ALDH1A1 (0.53) TDP1ALDH1A1CYP3A4HTTALOX15
SCHEMBL28857833 0.77 TDP1 (0.57) TDP1ALDH1A1CYP3A4TSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1554271-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS Rigel Pharmaceuticals, Inc. (US) 2005-07-20 EP disclosed
WO-2004035571-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS RIGEL PHARMACEUTICALS, INC. (US) 2004-04-29 WO disclosed